According to a recent LinkedIn post from Charlie Health, the company’s leadership is set to participate in two Becker’s Healthcare conferences in Chicago next week. The post highlights upcoming panel appearances by both co-founders, suggesting an effort to raise visibility among healthcare executives and decision-makers.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
At Becker’s Healthcare Annual Meeting, CEO and Co-Founder Carter Barnhart is described as joining a panel on optimizing patient-centered ambulatory services in the digital age. The post indicates that Charlie Health intends to position its high-acuity behavioral health offering within broader ambulatory and digital-care strategies.
At Becker’s Behavioral Health Summit, Chief Clinical Officer and Co-Founder Dr. Caroline Fenkel is slated to speak on building sustainable, clinically rigorous behavioral health models. This emphasis on sustainability and clinical quality may signal a focus on demonstrating outcomes and durability of the company’s care model to payors and provider partners.
For investors, this conference presence suggests ongoing business development and thought-leadership activity in a competitive behavioral health market. Increased exposure at Becker’s events could support relationship-building with health systems and insurers, potentially influencing future partnership pipelines and reimbursement opportunities.
The dual focus on digital ambulatory integration and sustainable behavioral health models also aligns with broader industry trends toward value-based and technology-enabled care. If these themes resonate with stakeholders at the conferences, Charlie Health could strengthen its strategic positioning in high-acuity behavioral healthcare and enhance its long-term growth prospects.

